THERAZONE ApS: Financial statements 2019
CVR: 27255574
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 12,656 and a net result of DKK 7,673,690 compared with DKK -233,374 the year before. Equity in the 2019 report amounted to DKK 34,421,852. The solvency ratio was 99.7%.
- Gross Profit
- DKK 12,656
- Profit/Loss
- DKK 7,673,690
- Equity
- DKK 34,421,852
- Total Assets
- DKK 34,516,741
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 13 t. | 7.7 mio. | 34.4 mio. | - |
| 2018 | - | -221 t. | -233 t. | 26.9 mio. | - |
| 2017 | - | -245 t. | 43.7 mio. | 45.1 mio. | - |
| 2016 | - | 238 t. | 453 t. | 1.3 mio. | - |
| 2015 | - | 25 t. | 485 t. | 890 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
THERAZONE ApS has published its annual report for 2018. Gross profit came to DKK -221,164, and the net result was DKK -233,374.
About THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. The company has 2 employees (2026). In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.